Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
La subida del viernes es por el acuerdo con merck que nadie lo esperaba
Lo otro ya se sabía en enero 15kilos colocados entre inversores (QI)cualificados.
No hay valor dilutivo en absoluto, es más refuerza el capital.
20-Jan-2012
Entry into a Material Definitive Agreement, Financial Statements an
Item 1.01. Entry into a Material Definitive Agreement.
Effective January 20, 2012, Threshold Pharmaceuticals, Inc. (the "Company") entered into an amendment (the "First Amendment") to the At Market Issuance Sales Agreement (the "Agreement"), dated October 29, 2010, between the Company and MLV & Co., LLC, formerly McNicoll, Lewis & Vlak LLC ("MLV"), pursuant to which the Company may issue and sell shares of its common stock from time to time through MLV as its sales agent.
The First Amendment amends the Agreement to increase the aggregate offering price of the Company's common stock that may be sold pursuant to the Agreement from $15,000,000 to $17,578,960 and to provide that those shares of common stock shall be sold pursuant to the Company's Registration Statement on Form S-3 (Registration No. 333-174844), which was declared effective by the Securities and Exchange Commission on July 7, 2011.
The foregoing description of the First Amendment is only a summary and is qualified in its entirety by reference to the First Amendment, a copy of which is filed as an exhibit to this Current Report on Form 8-K and to the Agreement, a copy of which was filed as an exhibit to the Company's Current Report on Form 8-K filed on October 29, 2010.
